טוען...
CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia
Although human genetics has resulted in the identification of novel lipid-related genes that can be targeted for the prevention of atherosclerotic vascular disease, medications targeting these genes or their protein products have short-term effects and require frequent administration during the cour...
שמור ב:
| הוצא לאור ב: | Arterioscler Thromb Vasc Biol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5832026/ https://ncbi.nlm.nih.gov/pubmed/28838920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.117.309326 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|